Adachi, Y., Tamiya, A., Taniguchi, Y., Enomoto, T., Azuma, K., Kouno, S., . . . Atagi, S. (2019). Predictive factors for progression‐free survival in non‐small cell lung cancer patients receiving nivolumab based on performance status. Cancer Med.
Dyfyniad Arddull ChicagoAdachi, Yuichi, et al. "Predictive Factors for Progression‐free Survival in Non‐small Cell Lung Cancer Patients Receiving Nivolumab Based On Performance Status." Cancer Med 2019.
Dyfyniad MLAAdachi, Yuichi, et al. "Predictive Factors for Progression‐free Survival in Non‐small Cell Lung Cancer Patients Receiving Nivolumab Based On Performance Status." Cancer Med 2019.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.